SeniorJournal.com - Daily News for Senior Citizens

  FRONT PAGE Aging • Health • Alzheimer's - Mental • Nutrition • Medicare & Medicaid Politics  • Fitness  • Social Security • Alerts • Sex Health • Features • Retirement  Elder Care  >Search  >Senior Links

[NavBar.htm]

Senior Journal: Today's News and Information for Senior Citizens & Baby Boomers

More Senior Citizen News and Information Than Any Other Source - SeniorJournal.com

• Go to more on Health & Medicine or More Senior News from SeniorJournal.com on the Front Page

 
 
Follow on  and 

E-mail this page to a friend!

Health & Medicine for Senior Citizens

Millions of Senior Women at High Risk of Breast Cancer May Get Preventive Drugs Free

Estimates are that over 10 million women in U.S.age  35 to 79 could be eligible for tamoxifen chemoprevention on the basis of their risk factors; Obamacare

By Phil Galewitz, Capsules, Kaiser Health News

Jan. 12, 2014 - Starting next September, women at increased risk for breast cancer will be able to get some drugs shown to help prevent the disease without a co-pay, the Obama administration said Thursday.

The U.S. Preventive Services Task Force  recommended last September that clinicians give medications such as tamoxifen or raloxifene to such women to reduce their risk of the disease. Under the Affordable Care Act, items or services rated A or B by the independent review board of physicians and academics must be covered by insurers without a co-pay or deductible. Insurers are given a year to make the change.

A spokesman for the insurance industry noted that while helping breast cancer patients get care is “a top priority for health plans,”  prescription drugs are not “free,” and the costs of those drugs would be reflected in the premiums that all consumers pay for coverage.

In addition, “we are concerned about the precedent of expanding the definition of prevention to now include some treatments that must be covered with no cost-sharing,” said the spokesman, Robert Zirkelbach of America’s Health Insurance Plans (AHIP).

Some of this information is reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

The American Cancer Society Cancer Action Network praised the requirement,  saying it would help more women stay healthy, thereby saving money in the long term.

“This policy means millions of women at high risk for breast cancer will know they can access proven risk-reducing medications at no cost to them,” said spokesman Steve Weiss.

 

Related Archive Stories

 
 

Metastatic Breast Cancer Patients May Not Benefit from Surgery, Radiation after Chemotherapy

Study found there was a 7 percent excess death rate in those who received treatment with radiotherapy and surgery

Dec. 11, 2013

High Cholesterol Fuels Growth, Spread of Breast Cancer; Statins Diminish Effect

‘Very significant finding’ especially for older women, suggests there may be simple way to reduce the risk of breast cancer by keeping cholesterol in check

Dec. 1, 2013

Multivitamins with Minerals May Save Lives of Older Women with Invasive Breast Cancer

WOW - Following years of bashing multivitamins, there is possibility they are lifesaver for senior women ages 50 to 79 - See information on below news report

October 10, 2013

Success of Cancer Chemotherapy Appears Enhanced by Blood Pressure Drug

Oct. 2, 2013

Diabetes Not Only Increases Risk of Breast and Colon Cancer but Death from Them, Too

Sept. 27, 2013


 
 

Read the latest news
> Health & Medicine
>
Today's Headlines

 

“Studies show that even modest cost-sharing can keep patients from taking advantage of proven preventive tests and therapies. By making prevention more accessible and affordable, the health care law is helping people stay healthy and avoid the high costs of treatment after diagnosis.”

A 2010 study  found that about 52,000 women were taking tamoxifen, yet the researchers wrote “in 2000, there would have been some 10 million women in the United States 35 to 79 years of age who were eligible for tamoxifen chemoprevention on the basis of their risk factors … For 2.4 million of these women, it was believed that the benefits of taking tamoxifen outweighed the risks.”

 Who Are the High Risk Women

The U.S. Preventative Services Task Force (USPSTF) decided against the routine use of tamoxifen or raloxifene drugs in women who are at average risk for getting breast cancer, because the risk of side effects outweighs the potential benefit.

They made the strong recommendation, however, that women with an estimated 5-year breast cancer risk of 3% or more, and low risk for side effects, should consider taking tamoxifen or raloxifene.

The women who might fit this "estimated 5-year risk of 3% or more" have (or have had):

- Older age (above 55)

- A family history of breast or ovarian cancer before the age of 50

- A personal history of atypical hyperplasia in a breast biopsy

- Pre-cancer DCIS; (intraductal carcinoma); LCIS (lobular carcinoma in situ)

- Extremely dense breast tissue on mammograms

- Started their periods early and/or were pregnant late

- Certain benign (not cancerous) breast conditions

Source: American Cancer Society

> Medical Malpractice,

> Nursing Home Abuse,

> Personal Injury

Our Experienced Lawyers Can Help

Beth Janicek, Board Certified Personal Injury Attorney"We win because we care, we prepare and we have no fear," Beth Janicek, board certified personal injury attorney

 

Free Consultation on your case.

Call Now Toll Free

1-877-795-3425

or Send Email

More at our Website

 

 

Search for more about this topic on SeniorJournal.com

Google Web SeniorJournal.com

Keep up with the latest news for senior citizens, baby boomers

 

Click to More Senior News on the Front Page

Copyright: SeniorJournal.com

    

 

Published by New Tech Media - www.NewTechMedia.com

Other New Tech Media sites include CaroleSutherland.com, BethJanicek.com, SASeniors.com, DrugDanger.com, etc.